The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


BXP BEXIMCO PHARMACEUTICALS LIMITED GDR (EACH REPR 1 ORD BDT10)(REGS)

BEXIMCO PHARMA  Currency  GBX 


Income Statement  (£ m) 31-Dec-12 31-Dec-11 31-Dec-10 31-Dec-09 31-Dec-08
Continuing Operations
Revenue  71.70 62.15 58.86 43.67 39.68
Operating Profit/(Loss)  17.04 15.66 14.83 8.98 9.88
Net Interest  4.98 4.47 4.61 2.60 2.47
Profit Before Tax  14.74 13.22 12.35 7.78 7.07
Profit After Tax  10.18 9.44 9.54 5.60 5.40
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  10.18 9.44 9.54 5.60 5.40
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  10.18 9.44 9.54 5.60 5.40
 
Continuing EPS
Earnings per Share - Basic  3.34p 3.10p 3.79p 3.14p 3.57p
Earnings per Share - Diluted  3.34p 3.10p 3.79p 3.14p 3.57p
Earnings per Share - Adjusted  3.34p 3.10p 3.79p 3.14p 3.57p
Continuing and Discontinued EPS
Earnings per Share - Basic  3.34p 3.10p 3.79p 3.14p 3.57p
Earnings per Share - Diluted  3.34p 3.10p 3.79p 3.14p 3.57p
Earnings per Share - Adjusted  3.34p 3.10p 3.79p 3.14p 3.57p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.37p

Balance Sheet  (£ m) 31-Dec-12 31-Dec-11 31-Dec-10 31-Dec-09 31-Dec-08
Assets
Non-Current Assets
Property, Plant & Equipment  106.98 109.43 112.86 104.20 55.80
Intangible Assets  1.44 1.07 0.46 0.05 0.00
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.03 0.03 0.06 0.03 0.36
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  18.08 14.60 24.28 12.10 62.16
  126.53 125.13 137.66 116.38 118.32
Current Assets
Inventories  18.79 18.05 17.99 17.63 14.89
Trade & Other Receivables  19.48 16.89 17.02 6.23 12.39
Cash at Bank & in Hand  4.27 4.09 13.34 9.49 0.73
Current Asset Investments  20.74 17.28 7.79 28.70 0.31
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  63.28 56.31 56.14 62.04 28.32
 
Total Assets  189.81 181.43 193.80 178.42 146.63
 
Liabilities
Current Liabilities
Borrowings  -16.91 -15.80 -18.03 -15.79 -20.88
Other Current Liabilities  -6.75 -5.06 -4.76 -5.03 -4.87
  -23.66 -20.86 -22.79 -20.82 -25.75
 
Net Current Assets  39.62 35.45 33.36 41.22 2.57
 
Non-Current Liabilities
Borrowings  -11.34 -14.89 -17.25 -17.27 -14.31
Provisions  -8.86 -7.59 -5.87 -3.16 -0.46
Other Non-Current Liabilities  -3.86 -3.18 -3.05 -39.53 -2.72
  -24.06 -25.66 -26.16 -59.96 -17.49
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -47.72 -46.52 -48.95 -80.78 -43.23
 
Net Assets  142.09 134.92 144.85 97.64 103.40
 
Capital & Reserves
Share Capital  23.52 19.83 19.03 13.56 12.46
Share Premium Account  53.72 54.82 47.78 13.36 14.74
Other Reserves  13.13 13.88 31.91 32.31 36.57
Retained Earnings  51.73 46.39 46.13 38.41 39.63
Shareholders Funds  142.09 134.92 144.85 97.64 103.40
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  142.09 134.92 144.85 97.64 103.40

Ratios - based on IFRS 31-Dec-12 31-Dec-11 31-Dec-10 31-Dec-09 31-Dec-08
Continuing Operations
PE Ratio - Adjusted  5.35 8.31 12.40 8.92 3.64
PEG - Adjusted  0.67 -0.45 0.60 -0.74 0.05
Earnings per Share Growth - Adjusted  7.95% -18.31% 20.74% -12.12% 72.98%
Dividend Cover  n/a n/a n/a n/a 9.68
Revenue Per Share  23.54p 20.40p 23.38p 24.46p 26.25p
Pre-Tax Profit per Share  4.84p 4.34p 4.90p 4.36p 4.67p
Operating Margin  27.51% 28.46% 21.92% 23.99% 24.90%
Return on Capital Employed  10.86% 10.09% 8.99% 7.60% 6.73%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 2.84%
Dividend per Share Growth  n/a n/a n/a -100.00% n/a
Net Asset Value per Share (exc. Intangibles)  46.17p 237.08p 68.82p 64.56p 82.09p
Net Gearing  16.88% 19.72% 15.15% 24.13% 33.33%

Data is provided by Morningstar


BEXIMCO PHARMA share - fundamentals

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds